Navigation Links
New Minimally Invasive Breast Reconstructive Procedure for Breast Cancer Patients - Actively Recruiting Participants for Clinical Study
Date:10/16/2007

MIAMI, Oct. 16 /PRNewswire/ -- Roger K. Khouri, M.D. a noted Plastic and Reconstructive Surgeon, is presently leading a team of surgeons in a clinical trial performing a minimally invasive breast reconstruction technique utilizing the Brava external expansion system and liposuctioned micro-fat grafts primarily on women who have had a mastectomy or lumpectomy, with or without radiation therapy.

Typically, breast reconstruction procedures involve major, "open" surgery that requires extensive recovery time. With this new minimally-invasive outpatient breast reconstruction technique, the chest wall is first expanded by using the Brava System and is followed by the re-injection of small micro- grafts that are harvested, through a liposuction procedure, from the patients own body (autologous grafts). These micro-fat grafts are most often harvested from the patient's thighs, buttocks and stomach. A key element to the success of this procedure, an average 90% graft survival rate, is the preparation of the recipient breast site with the expansion device (Brava) enabling greater volumes of fat to be transferred, and its post operative use to stabilize the graft ensuring its survival. Slowly, after undergoing a few procedures, the breasts are reconstructed. Following each treatment, patients are ambulatory and recovery time is minimal.

The study is actively recruiting the following types of participants: post lumpectomy patients, post mastectomy patients or those post breast biopsy, that were left with a filling defect, who do not have breast implants. Further information about the clinical trial and enrollment criteria may be found at http://www.clinicaltrials.gov/ct/show/NCT00466765?order=1

About Dr. Khouri

Roger K. Khouri, M.D., is a world renowned plastic and reconstructive surgeon practicing in Miami, FL and the inventor of the Brava System. Prior to co-founding Brava, LLC, Dr. Khouri held professional and fellowship positions at Brown, Harvard, New York and Washington Universities.

About Brava, LLC

Brava, LLC, founded in 1999, is a medical device manufacturer. Products include the Brava Breast Enhancement System. Brava, LLC headquarters are located at 14221 S.W. 142nd Street, Miami, FL 33186


'/>"/>
SOURCE Brava, LLC
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Non-Invasive Diagnostic Tests for Celiac Disease
2. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
3. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
4. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
5. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
6. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
7. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
8. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
9. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
10. Clinical Results From EntreMeds Panzem NCD and Taxol Breast Cancer Study Presented at ASCO
11. New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by Paclitaxel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mass. , March 23, 2017 Merrimack ... enrollment of its first patient in a Phase 1 ... antibody-directed nanotherapeutic (ADN) that encapsulates a novel taxane and ... is overexpressed in 50-100% of many major tumor types, ... "The initiation of this study is an ...
(Date:3/23/2017)... , March 23, 2017 Global Colposcope Market ... on the Colposcope in Global market, especially in North ... Asia-Pacific , South America , ... report categorizes the market based on manufacturers, regions, type and application. ... Browse 190 Tables ...
(Date:3/23/2017)... 23, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... that the English version of the Annual report for 2016 ... ... NeuroVive NeuroVive Pharmaceutical AB is a leader in ... development of medicines that preserve mitochondrial integrity and function in ...
Breaking Medicine Technology:
(Date:3/23/2017)... Rey, CA (PRWEB) , ... March 23, 2017 ... ... its customizable coding audit software solution, iCode Assurance, at HCCA’s 21st annual Compliance ... optimizes and accelerates the coding audit process for all medical chart types with ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “Wounded Woman ... “Wounded Woman Be Ye Healed-Passing On A Legacy” is the creation of published author, ... founder of Comfortbearers grief ministry. She has been happily married to her husband, ...
(Date:3/23/2017)... ... 2017 , ... “A Respectful Response To Atheist Manifesto”: theological ... Manifesto” is the creation of published author Richard Hostetter, a former missionary in ... holds graduate degrees from Kent State University and the University of Ghana. , ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... the publication of “Profiling protein expression in circulating tumor cells using microfluidic western ... the use of the Vortex technology to capture CTCs and a ...
(Date:3/22/2017)... (PRWEB) , ... March 23, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... BioPharma Asia Convention, currently taking place at the Suntec Singapore International Exhibition & ...
Breaking Medicine News(10 mins):